Literature DB >> 25111615

The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma.

Nicholas M Bernthal1, Angelica Putnam, Kevin B Jones, David Viskochil, R Lor Randall.   

Abstract

BACKGROUND AND OBJECTIVES: While convention defines atypical neurofibroma as benign and low-grade malignant peripheral nerve sheath tumors (MPNSTs) as malignant, sparse outcomes data exist for these tumors. This study reviews clinical outcomes of surgically resected low-grade MPNST and atypical neurofibroma, focusing on the effect of surgical margins on outcome.
METHODS: This study is a retrospective review of 23 patients who underwent surgical resection of a low-grade MPNST or atypical neurofibroma. Treatment characteristics of adjuvant therapy and surgical margin were noted. Endpoints of local recurrence, presence of metastatic disease, disease-specific survival, and overall survival were reviewed.
RESULTS: Eighteen of 23 patients (78%) had microscopically positive margins on the resection. Disease-specific survival was 100% for both atypical neurofibroma patients and those with low-grade MPNST, regardless of surgical margin. Local recurrence in terms of recurrence of measureable disease occurred in 2/12 (16.7%) of LGMPNST patients and 1/11 (9.1%) of atypical NF patients, all of whom had microscopically positive surgical margins.
CONCLUSIONS: In a study dedicated exclusively to "intermediate" nerve sheath tumors, no patients developed metastatic disease nor died of disease despite a high rate of microscopically positive surgical margins (78%). While positive margins did lead to increased rates of local recurrence, these data suggest that surgeons potentially can temper their zeal for negative surgical margins in the setting of low-grade MPNST and atypical neurofibroma, as surgical morbidity may be more important than a presumed survival benefit of wide resection.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  MPNST; atypical neurofibroma; low grade MPNST; nerve sheath tumor; neurofibromatosis

Mesh:

Year:  2014        PMID: 25111615     DOI: 10.1002/jso.23736

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  15 in total

1.  The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.

Authors:  Christine S Higham; Eva Dombi; Aljosja Rogiers; Sucharita Bhaumik; Steven Pans; Steve E J Connor; Markku Miettinen; Raf Sciot; Roberto Tirabosco; Hilde Brems; Andrea Baldwin; Eric Legius; Brigitte C Widemann; Rosalie E Ferner
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 12.300

2.  Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.

Authors:  Eric Legius; Hilde Brems
Journal:  Childs Nerv Syst       Date:  2020-06-29       Impact factor: 1.475

3.  Diffusion-weighted imaging and diffusion tensor imaging as adjuncts to conventional MRI for the diagnosis and management of peripheral nerve sheath tumors: current perspectives and future directions.

Authors:  Alexander T Mazal; Oganes Ashikyan; Jonathan Cheng; Lu Q Le; Avneesh Chhabra
Journal:  Eur Radiol       Date:  2018-12-07       Impact factor: 5.315

Review 4.  What's new in nerve sheath tumors.

Authors:  Anders Meyer; Steven D Billings
Journal:  Virchows Arch       Date:  2019-11-09       Impact factor: 4.064

Review 5.  Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.

Authors:  Justin Korfhage; David B Lombard
Journal:  Mol Cancer Res       Date:  2019-04-25       Impact factor: 5.852

Review 6.  Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives.

Authors:  Brigitte C Widemann; Antoine Italiano
Journal:  J Clin Oncol       Date:  2017-12-08       Impact factor: 44.544

Review 7.  Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.

Authors:  Markku M Miettinen; Cristina R Antonescu; Christopher D M Fletcher; Aerang Kim; Alexander J Lazar; Martha M Quezado; Karlyne M Reilly; Anat Stemmer-Rachamimov; Douglas R Stewart; David Viskochil; Brigitte Widemann; Arie Perry
Journal:  Hum Pathol       Date:  2017-05-24       Impact factor: 3.466

8.  Synovial Sarcoma of the Nerve-Clinical and Pathological Features: Case Series and Systematic Review.

Authors:  Stephen Shelby Burks; Ross C Puffer; Iahn Cajigas; David Valdivia; Andrew E Rosenberg; Robert J Spinner; Allan D Levi
Journal:  Neurosurgery       Date:  2019-12-01       Impact factor: 4.654

9.  Low-grade Schwann cell neoplasms with leptomeningeal dissemination: clinicopathologic and autopsy findings.

Authors:  Erika F Rodriguez; Jaishri Blakeley; Shannon Langmead; Alessandro Olivi; Anthony Tufaro; Abeer Tabbarah; Gail Berkenblit; Justin M Sacks; Scott D Newsome; Elizabeth Montgomery; Fausto J Rodriguez
Journal:  Hum Pathol       Date:  2016-09-22       Impact factor: 3.466

10.  Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.

Authors:  Kelsey L Watson; Ghadah A Al Sannaa; Christine M Kivlin; Davis R Ingram; Sharon M Landers; Christina L Roland; Janice N Cormier; Kelly K Hunt; Barry W Feig; B Ashleigh Guadagnolo; Andrew J Bishop; Wei-Lien Wang; John M Slopis; Ian E McCutcheon; Alexandar J Lazar; Keila E Torres
Journal:  J Neurosurg       Date:  2016-04-01       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.